HIF-PH inhibitor (Hangzhou Huadong Medicine Group Pharmaceutical Research Institute)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHIF-PH inhibitor (Hangzhou Huadong Medicine Group Pharmaceutical Research Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHangzhou Huadong Medicine Group Biotechnology Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHangzhou Huadong Medicine Group Biotechnology Institute Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A